Lam B.Y.K., Yiu B., Ampil E., Chen C.L.-H., Dikot Y., Dominguez J.C., Ganeshbhai P.V., Hilal S., Kandiah N., Kim S.Y., Lee J.-Y., Ong A.P., Senanarong V., Leung K.T., Wang H., Yang Y.-H., Yong T., Arshad F., Alladi S., Wong S., Ko H., Lau A.Y.L., Mok V.C.T.
Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong; Therese Pei Fong Chow Research Centre for Prevention of Dementia and Margaret Kam Ling Cheung Research Centre for Management of Parkinsonism, Gerald Choa Neuroscience Centre, The Chinese University of Hong Kong, Hong Kong; Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, China; Department of Neuroscience and Behavioural Medicine, Faculty of Medicine and Surgery, University of Santo Tomas, Manila, Philippines; Institute for Neurosciences, St. Luke’s Medical Centre, Quezon City, Philippines; Memory Aging and Cognition Center, National University Health System, Singapore, Singapore; Department of Pharmacology, National University of Singapore, Singapore, Singapore; Department of Neurology, Achmad Yani University, Cimahi, Indonesia; Department of Neurology, National Institute of Mental Health and Neuro Sciences, Bengaluru, India; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, Singapore; Department of Neurology, National Neuroscience Institute, Singapore, Singapore; Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seoul, South Korea; Department of Psychiatry, SMG-SNU Boramae Medical Centre, Seoul National University College of Medicine, Seoul, South Korea; Department of Neurology, Hasan Sadikin Hospital, Bandung, Indonesia; Department of Medicine At, Mahidol University, Bangkok, Thailand; Dementia Care and Research Centre, Peking University Institute of Mental Health, Beijing, China; Department of Neurology, Kaohsiung Municipal Ta-Tung Hospital and Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong; Li Ka Shing Institute of Health Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong
Age-related white matter lesion (WML) is considered a manifestation of sporadic cerebral small vessel disease and an important pathological substrate for dementia. Asia is notable for its large population with a looming dementia epidemic. Yet, the burden of WML and its associated risk factors across different Asian societies are unknown. Subjects from 9 Asian cities (Bangkok, Bandung, Beijing, Bengaluru, Hong Kong, Kaohsiung, Manila, Seoul, and Singapore) were recruited (n = 5701) and classified into (i) stroke/transient ischemic attack (TIA), (ii) Alzheimer’s disease (AD)/mild cognitive impairment (MCI), or (iii) control groups. Data on vascular risk factors and cognitive performance were collected. The severity of WML was visually rated on MRI or CT. The prevalence of moderate-to-severe WML was the highest in subjects with stroke/TIA (43.3%). Bandung Indonesia showed the highest prevalence of WML, adjusted for age, sex, education, disease groups, and imaging modality. Hypertension and hyperlipidemia were significant risk factors for WML, and WML was negatively associated with MMSE in all groups. WML is highly prevalent in Asia and is associated with increasing age, hypertension, hyperlipidemia, and worse cognitive performance. Concerted efforts to prevent WML will alleviate the huge dementia burden in the rapidly aging Asian societies. © 2021, The Author(s).
Publisher: Nature Research
Volume 11, Issue 1, Art No 11587, Page – , Page Count
Journal Link: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85107213249&doi=10.1038%2fs41598-021-90746-x&partnerID=40&md5=a1fac18be2a4daf41f2b3ce3f93c6923
Type: All Open Access, Gold, Green
Prince, M.J., Wimo, A., Guerchet, M.M., Ali, G.C., Wu, Y.-T., Prina, M., World Alzheimer Report 2015 – The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends (2015) London: Alzheimer’s Disease International, p. 84; Toledo, J.B., Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre (2013) Brain, 136, pp. 2697-2706; Wardlaw, J.M., Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) Lancet Neurol., 12, pp. 822-838; Smith, E.E., Schneider, J.A., Wardlaw, J.M., Greenberg, S.M., Cerebral microinfarcts: the invisible lesions (2012) Lancet Neurol., 11, pp. 272-282; Jokinen, H., Post-stroke cognitive impairment is common even after successful clinical recovery (2015) Eur. J. Neurol., 22, pp. 1288-1294; Wen, H.M., Effect of white matter changes on cognitive impairment in patients with lacunar infarcts (2004) Stroke; Wang, Z., Cerebral microbleeds and cognitive function in ischemic stroke or transient ischemic attack patients (2015) Dement. Geriatr. Cogn. Disord., 40, pp. 130-136; Wang, Z., Risk factors and cognitive relevance of cortical cerebral microinfarcts in patients with ischemic stroke or TIA (2016) Stroke, 47, pp. 2450-2455; Mok, V.C.T., Early-onset and delayed-onset poststroke dementia – revisiting the mechanisms (2017) Nat. Rev. Neurol., 13, pp. 148-159; De Groot, J.C., Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study (2000) Ann. Neurol. Off. J. Am. Neurol. Assoc. Child Neurol. Soc., 47, pp. 145-151. , COI: 1:STN:280:DC%2BD3c7islamsg%3D%3D; Kao, Y.-H., Chou, M.-C., Chen, C.-H., Yang, Y.-H., White matter changes in patients with Alzheimer’s disease and associated factors (2019) J. Clin. Med., 8, p. 167; Mok, V.C.T., Cognitive impairment and functional outcome after stroke associated with small vessel disease (2004) J. Neurol. Neurosurg. Psychiatry, 75, pp. 560-566; Pendlebury, S.T., Rothwell, P.M., Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis (2009) Lancet Neurol., 8, pp. 1006-1018; Prasad, K., Wiryasaputra, L., Ng, A., Kandiah, N., White matter disease independently predicts progression from mild cognitive impairment to Alzheimer’s disease in a clinic cohort (2011) Dement. Geriatr. Cogn. Disord., 31, pp. 431-434; Kim, S., Periventricular white matter hyperintensities and the risk of dementia: a CREDOS study (2015) Int. Psychogeriatr., 27, p. 2069; Alosco, M.L., A clinicopathological investigation of white matter hyperintensities and Alzheimer’s disease neuropathology (2018) J. Alzheimer’s Dis. JAD, 63, pp. 1347-1360; Lee, S., White matter hyperintensities are a core feature of Alzheimer’s disease: evidence from the dominantly inherited Alzheimer network (2016) Ann. Neurol., 79, pp. 929-939; Ding, D., White matter hyperintensity predicts the risk of incident cognitive decline in community dwelling elderly (2018) J. Alzheimers Dis., 61, pp. 1333-1341. , COI: 1:CAS:528:DC%2BC1cXhslSjtbY%3D; Debette, S., Markus, H.S., The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis (2010) BMJ, 341, pp. 1-9; Inzitari, D., Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort (2009) BMJ; Jorgensen, D.R., A population neuroscience approach to the study of cerebral small vessel disease in midlife and late life: an invited review (2018) Am. J. Physiol. Heart Circ. Physiol., 314, pp. H1117-H1136. , COI: 1:CAS:528:DC%2BC1cXhvV2mtb%2FN; Marini, S., Anderson, C.D., Rosand, J., Genetics of cerebral small vessel disease (2020) Stroke, 51, pp. 12-20; Mok, V., Race-ethnicity and cerebral small vessel disease—comparison between Chinese and White populations (2014) Int. J. Stroke, 9, pp. 36-42; Hiremath, N., Kate, M., Mohimen, A., Kesavadas, C., Sylaja, P.N., Risk factors of white matter hyperintensities in South Asian patients with transient ischemic attack and minor stroke (2020) Neuroradiology; Ren, X.-M., White matter lesions predict recurrent vascular events in patients with transient ischemic attacks (2018) Chin. Med. J. (Engl.), 131, pp. 130-136; Lee, S.-J., The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke (2008) BMC Neurol., 8, p. 31; Hilal, S., Prevalence, risk factors and consequences of cerebral small vessel diseases: data from three Asian countries (2017) J. Neurol. Neurosurg. Psychiatry, 88, p. 669; McKhann, G., (1984) Clinical Diagnosis of Alzheimer’s Disease. Report of the NINCDS‐ADRDA Work Group* under the Auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease 34, pp. 939-939. , https://doi.org/10.1212/wnl.34.7.939; Sacco, R.L., An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association (2013) Stroke, 44, pp. 2064-2089; Li, H., Jia, J., Yang, Z., Mini-mental state examination in elderly Chinese: a population-based normative study (2016) J. Alzheimers Dis., 53, pp. 487-496; Román, G.C., Vascular dementia: diagnostic criteria for research studies (1993) Neurology, 43, p. 250; Yang, J., Risk factors for incident dementia after stroke and transient ischemic attack (2015) Alzheimers Dement., 11, pp. 16-23; Fazekas, F., Chawluk, J.B., Alavi, A., Hurtig, H.I., Zimmerman, R.A., MR signal abnormalities at 1.5 T in Alzheimer’s dementia and normal aging (1987) Am. J. Roentgenol., 149, pp. 351-356; Xiong, Y., Operational definitions improve reliability of the age-related white matter changes scale (2011) Eur. J. Neurol., 18, pp. 744-749; Inzitari, D., Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study (2007) Arch. Intern. Med., 167, pp. 81-88; Ferguson, K., Visual rating scales of white matter hyperintensities and atrophy: comparison of computed tomography and magnetic resonance imaging (2018) J. Stroke Cerebrovasc. Dis., 27, pp. 1-8; Jin, H., Prevalence and risk factors of white matter lesions in Tibetan patients without acute stroke (2020) Stroke, 51, pp. 149-153; O’donnell, M.J., Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study (2010) Lancet, 376, pp. 112-123; Sudre, C.H., Cardiovascular risk factors and white matter hyperintensities: difference in susceptibility in South Asians compared with Europeans (2018) J. Am. Heart Assoc., 7; Ossenkoppele, R., Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis (2015) JAMA, 313, pp. 1939-1949; Ylikoski, A., White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home (1995) Stroke, 26, pp. 1171-1177; de Leeuw, F.E., Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study (2001) J. Neurol. Neurosurg. Psychiatry, 70, pp. 9-14; Schmidt, R., Enzinger, C., Ropele, S., Schmidt, H., Fazekas, F., Progression of cerebral white matter lesions: 6-year results of the Austrian stroke prevention study (2003) Lancet, 361, pp. 2046-2048; van Dijk, E.J., Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan Study (2008) Stroke, 39, pp. 2712-2719; Jimenez-Conde, J., Hyperlipidemia and reduced white matter hyperintensity volume in patients with ischemic stroke (2010) Stroke, 41, pp. 437-442; Longstreth, W., Jr., Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study (2005) Stroke, 36, pp. 56-61; De Bresser, J., Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes (2010) Diabetes Care, 33, pp. 1309-1314; Kooistra, M., Diabetes mellitus and progression of vascular brain lesions and brain atrophy in patients with symptomatic atherosclerotic disease. The SMART-MR study (2013) J. Neurol. Sci., 332, pp. 69-74. , COI: 1:CAS:528:DC%2BC3sXhtVOjur7J; Van Elderen, S., Progression of brain atrophy and cognitive decline in diabetes mellitus: a 3-year follow-up (2010) Neurology, 75, pp. 997-1002; Shim, Y.S., Yang, D.W., Kim, H.-J., Park, Y.H., Kim, S., Characteristic differences in the mini-mental state examination used in Asian countries (2017) BMC Neurol., 17, p. 141; Mok, V.C., Delayed-onset dementia after stroke or transient ischemic attack (2016) Alzheimers Dement., 12, pp. 1167-1176; van Middelaar, T., Effect of antihypertensive medication on cerebral small vessel disease: a systematic review and meta-analysis (2018) Stroke, 49, pp. 1531-1533; Livingston, G., Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) The Lancet, 396, pp. 413-446; Nasrallah, I.M., Association of intensive vs standard blood pressure control with cerebral white matter lesions (2019) JAMA, 322, pp. 524-534; Williamson, J.D., Effect of intensive vs standard blood pressure control on probable dementia: a randomized clinical trial (2019) JAMA, 321, pp. 553-561; Ott, B.R., Do statins impair cognition? A systematic review and meta-analysis of randomized controlled trials (2015) J. Gen. Intern. Med., 30, pp. 348-358; Zhang, H., Effects of sartans and low-dose statins on cerebral white matter hyperintensities and cognitive function in older patients with hypertension: a randomized, double-blind and placebo-controlled clinical trial (2019) Hypertens. Res., 42, pp. 717-729. , COI: 1:CAS:528:DC%2BC1cXisFegsb3I
Indexed by Scopus